Kevin Schifferli

413 citations
12 papers · 217 indexed · h-index 7
Topics
Amino Acid Enzymes and Metabolism (4 papers)CAR-T cell therapy research (2 papers)Cancer, Hypoxia, and Metabolism (2 papers)
Journals
Nature CommunicationsSHILAP Revista de lepidopterologíaBlood

In The Last Decade

Kevin Schifferli

11 papers receiving 213 citations

Peers

Kevin Schifferli
Comparison fields: 5 of 39
  • Rheumatology 87
  • Immunology 85
  • Oncology 78
  • Molecular Biology 74
  • Radiology, Nuclear Medicine and Imaging 69
Replace Rika Kato with:
Rika Kato Japan
Katy A. Lloyd United States
Annie Borch Denmark
Alexander A. Girgis United States
Elena Agape Italy
Winnie L. Kan Australia
Theresa Kissel Netherlands
Xiaoxia Qian China
Aurora Rizzo Italy
Banri Tsuda Japan
Kevin Schifferli relative to Rika Kato Japan Rika Kato's profile →
Citations per field
00.5×
Rika Kato · 1×
Citations per year

Countries citing papers authored by Kevin Schifferli

Since Specialization
Citations

This map shows the geographic impact of Kevin Schifferli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Schifferli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Schifferli more than expected).

Fields of papers citing papers by Kevin Schifferli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Schifferli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Schifferli. The network helps show where Kevin Schifferli may publish in the future.

Co-authorship network of co-authors of Kevin Schifferli

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Schifferli. A scholar is included among the top collaborators of Kevin Schifferli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Schifferli. Kevin Schifferli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 7
2 1
3 0
4 51
5 7
6 6
7 1
8 6
9 106
10 27
11 1
12 4

About Kevin Schifferli

Kevin Schifferli is a scholar working on Biochemistry, Immunology and Genetics, having authored 12 papers that have together received 217 indexed citations. Recurring topics across this work include Amino Acid Enzymes and Metabolism (4 papers), CAR-T cell therapy research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Rheumatology (87 citations), Immunology (85 citations) and Radiology, Nuclear Medicine and Imaging (69 citations). Kevin Schifferli has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Meina Liang, Chris Morehouse, Jeffrey M. Riggs, Richard N. Hanna, Bhargavi Rajan, Inna Vainshtein, Kamelia Zerrouki, Divya Sagar, Jodi L. Karnell and Gary P. Sims. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026